Results 91 to 100 of about 12,566 (189)

Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application. [PDF]

open access: yesContemp Clin Trials Commun, 2022
Buono FD   +7 more
europepmc   +1 more source

Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1). [PDF]

open access: yesChildren (Basel), 2021
Stavinoha PL   +5 more
europepmc   +1 more source

A novel neurofibromatosis type 1 (NF1) mutation in a patient with NF1 and pheochromocytoma [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2018
Seo, Yoorim   +6 more
openaire   +1 more source

Increased risk of breast cancer in neurofibromatosis type 1: current insights

open access: yesBreast Cancer: Targets and Therapy, 2017
Sacha J Howell,1 Kimberley Hockenhull,1 Zena Salih,1 D Gareth Evans2,3 1Department of Medical Oncology, The Christie NHS Foundation Trust, 2Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health,
Howell SJ   +3 more
doaj  

Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines. [PDF]

open access: yesPLoS One, 2021
Gu YH   +11 more
europepmc   +1 more source

Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques. [PDF]

open access: yesJ Bone Miner Res, 2022
Ahmed R   +6 more
europepmc   +1 more source

A neurofibromatosis type 1 family report with multiple cases in 3 consecutive Generations

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2017
Neurofibromatosis type1 (NF1) with the incidence of 1 in 3500 births, is the most common disorder which affects skin and peripheral nervous system. NF1 results from mutations in NF1 gene. The NF1 gene spans 350kbp and to date, nearly 2434 mutations in it
M Oladnabi   +4 more
doaj  

Home - About - Disclaimer - Privacy